이 특허를 인용한 특허 (74)

1. Bryant, John L., Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod.

   상세보기
2. Bryant, John L., Anti-ERBB2 antibody adjuvant therapy.

   상세보기
3. Fendly,Brian M., Anti-ErbB2 antibodies.

   상세보기
4. Gorczynski, Reginald M.; Wong, Karrie Ka Wai, Assay for soluble CD200.

   상세보기
5. Carney,Walter P.; Hamer,Peter J.; Lipton,Allan; Leitzel,Kim; Ali,Suhail M., Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples.

   상세보기
6. Hancock,Miriam E. C.; Monahan,John J.; Langton,Beatrice Claudia, C-erbB-2 external domain: GP75.

   상세보기
7. Clinton, Gail M., Compositions and methods for treating cancer by modulating HER-2 and EGF receptors.

   상세보기
8. Clinton,Gail M., Compositions and methods for treating cancer by modulating HER-2 and EGF receptors.

   상세보기
9. Cheever, Martin A.; Disis, Mary L., Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.

   상세보기
10. Cheever, Martin A; Disis, Mary L, Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.

    상세보기
11. Cheever, Martin A; Disis, Mary L, Compounds for eliciting or enhancing immune reactivity to HER-2/protein for prevention or treatment of malignancies in which the HER-2/oncogene is associated.

    상세보기
12. Mass, Robert D., Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy.

    상세보기
13. Baughman, Sharon A.; Shak, Steven, Dosages for treatment with anti-ErbB2 antibodies.

    상세보기
14. Baughman,Sharon A.; Shak,Steven, Dosages for treatment with anti-ErbB2 antibodies.

    상세보기
15. Derynck, Mika K.; Kelsey, Stephen M., Extending time to disease progression or survival in cancer patients.

    상세보기
16. Binder,Steven R.; Goodrich,Jodi L.; Safarian,Zara, FXIII detection for verifying serum sample and sample size and for detecting dilution.

    상세보기
17. Binder,Steven R.; Goodrich,Jodi L.; Safarian,Zara, FXIII detection for verifying serum sample and sample size and for detecting dilution.

    상세보기
18. Allison, David E.; Bruno, Rene; Lu, Jian-Feng; Ng, Chee M., Fixed dosing of HER antibodies.

    상세보기
19. Allison,David E.; Bruno,Rene; Lu,Jian Feng; Ng,Chee M., Fixed dosing of HER antibodies.

    상세보기
20. Mass, Robert D., Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy.

    상세보기
21. Mass, Robert D., Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy.

    상세보기
22. Mass, Robert D., Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy.

    상세보기
23. Lee-Hoeflich, Si Tuen; Stern, Howard, Gene expression markers of tumor resistance to HER2 inhibitor treatment.

    상세보기
24. Clinton, Gail M.; Evans, Adam; Henner, William D., HER-2 binding antagonists.

    상세보기
25. Doherty,Joni Kristin; Clinton,Gail M.; Adelman,John P., HER-2 binding antagonists.

    상세보기
26. Joni Kristin Doherty ; Gail M. Clinton, HER-2 binding antagonists.

    상세보기
27. Hudziak Robert Michael ; Shepard H. Michael ; Ullrich Axel, HER2 extracellular domain.

    상세보기
28. Hudziak Robert Michael ; Shepard H. Michael ; Ullrich Axel,DEX, HER2 extracellular domain.

    상세보기
29. Wicha, Max S.; Korkaya, Hasan, HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells.

    상세보기
30. Adams, Camellia W.; Presta, Leonard G.; Sliwkowski, Mark, Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies.

    상세보기
31. Adams, Camellia W.; Presta, Leonard G.; Sliwkowski, Mark, Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies.

    상세보기
32. Sliwkowski, Mark, Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies.

    상세보기
33. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is a.

    상세보기
34. Cheever, Martin A.; Disis, Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.

    상세보기
35. Cheever,Martin A; Disis,Mary L, Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.

    상세보기
36. Cheever, Martin A; Disis, Mary L, Immune reactivity to HER-2/protein for diagnosis and treatment of malignancies in which the HER-2/oncogene is associated.

    상세보기
37. Dennis, Mark; Marik, Jan; Polakis, Paul; Rubinfeld, Bonnee; Williams, Simon, Immuno-PET imaging of antibodies and immunoconjugates and uses therefor.

    상세보기
38. Streckfus, Charles F.; Bigler, Lenora G.; Thigpen, James Tate, Method of diagnosing and monitoring malignant breast carcinomas.

    상세보기
39. Streckfus, Charles F.; Bigler, Lenora G.; Thigpen, James Tate, Method of diagnosing and monitoring malignant breast carcinomas.

    상세보기
40. Clinton, Gail M., Method of treating cancer by inhibition of p95HER-2 production.

    상세보기
41. Cheever Martin A. ; Disis Mary L., Methods for eliciting or enhancing reactivity to HER-2/neu protein.

    상세보기
42. Hudziak Robert M. (Corvallis OR) Shepard H. Michael (Rancho Santa Fe CA) Ullrich Axel (Portola Valley CA) Fendly Brian M. (Half Moon Bay CA), Monoclonal antibodies directed to the HER2 receptor.

    상세보기
43. Hudziak Robert M. ; Shepard H. Michael ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.

    상세보기
44. Hudziak Robert M. ; Shepard H. Michael ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.

    상세보기
45. Hudziak Robert M. ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.

    상세보기
46. Robert M. Hudziak ; H. Michael Shepard ; Axel Ullrich ; Brian M. Fendly, Monoclonal antibodies directed to the HER2 receptor.

    상세보기
47. Robert M. Hudziak ; H. Michael Shepard ; Axel Ullrich ; Brian M. Fendly, Monoclonal antibodies directed to the HER2 receptor.

    상세보기
48. Gao, Wei-Qiang; Koeppen, Hartmut; Ross, Sarajane; Shou, Jianyong, Notch receptor agonists and uses.

    상세보기
49. Amici Augusto,ITX ; Concetti Antonio,ITX ; Venanzi Franco,ITX, Polynucleotide immunogenic agents.

    상세보기
50. Amler, Lukas C.; Birkner, Merrill; Lin, Chin-Yu; Moecks, Joachim; Strauss, Andreas, Predicting response to a HER inhibitor.

    상세보기
51. Amler, Lukas C.; Birkner, Merrill; Lin, Chin-Yu; Moecks, Joachim; Strauss, Andreas, Predicting response to a HER inhibitor.

    상세보기
52. Andya, James; Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Shire, Steven J.; Yang, Janet Yu-Feng; Wu, Sylvia Sau-Yan, Protein formulation.

    상세보기
53. Andya, James; Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Shire, Steven J.; Yang, Janet Yu-Feng; Wu, Sylvia Sau-Yan, Protein formulation.

    상세보기
54. Andya, James; Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Shire, Steven J.; Yang, Janet Yu-Feng; Wu, Sylvia Sau-Yan, Protein formulation.

    상세보기
55. Andya,James; Cleland,Jeffrey L.; Hsu,Chung C.; Lam,Xanthe M.; Overcashier,David E.; Shire,Steven J.; Yang,Janet Yu Feng; Wu,Sylvia Sau Yan, Protein formulation.

    상세보기
56. Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Yang, Janet Yu-Feng, Protein formulation.

    상세보기
57. Maihle, Nita J.; Reiter, Jill, Soluble epidermal growth factor receptor isoforms.

    상세보기
58. Pastorek, Jaromir; Pastorekova, Silvia; Zatovicova, Miriam; Zavada, Jan; Gut, Marta Ortova; Zavadova, Zuzanna, Soluble form of carbonic anhydrase IX (S-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/NEU/C-ERBB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes.

    상세보기
59. Pastorek, Jaromir; Pastorekova, Silvia; Zatovicova, Miriam; Zavada, Jan; Gut, Marta Ortova; Zavadova, Zuzanna, Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes.

    상세보기
60. Pastorek, Jaromir; Pastorekova, Silvia; Zatovicova, Miriam; Zavada, Jan; Gut, Marta Ortova; Zavadova, Zuzanna, Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes.

    상세보기
61. Andya, James; Hsu, Chung C.; Shire, Steven J.; Wu, Sylvia Sau-Yan, Treating a mammal with a formulation comprising an antibody which binds IgE.

    상세보기
62. Sliwkowski,Mark X., Treating prostate cancer with anti-ErbB2 antibodies.

    상세보기
63. Baughman, Sharon A.; Shak, Steven, Treatment with anti-ErbB2 antibodies.

    상세보기
64. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.

    상세보기
65. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.

    상세보기
66. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.

    상세보기
67. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.

    상세보기
68. Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.

    상세보기
69. Paton, Virginia E.; Shak, Steven; Hellmann, Susan D., Treatment with anti-ErbB2 antibodies.

    상세보기
70. Sliwkowski, Mark, Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs.

    상세보기
71. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark, Treatment with anti-ErbB2 antibodies and anti-hormonal compounds.

    상세보기
72. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark, Treatment with anti-ErbB2 antibodies and chemotherapeutic agents.

    상세보기
73. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark, Treatment with anti-ErbB2 antibody combinations.

    상세보기
74. Sliwkowski,Mark X.; Kern,Jeffrey A., Use of heregulin as a growth factor.

    상세보기
더보기